AI-Driven Precision Oncology Startup aiPTO Unveils #1-Ranked DELPHAI Model, Bridging the "Scale Gap" From Virtual Cells to Virtual TumorsaiPTO TechBio today released a preprint [link] describing DELPHAI (Deep Explainable Perturbation Heterogeneity-Aware Inference), its virtual tumor model for perturbation prediction. In two independent benchmarking frameworks (Wei et al., Nature Methods 2026; Radig et al., Genome Biology 2026), DELPHAI achieved the #1 ranking on differentially expressed gene (DEG) recovery, outperforming state-of-the-art virtual cell models. It predicts drug responses for previously unseen, out-of-distribution patients, with biologically explainable outputs.
